Roivant

News

Moderna agrees $950m settlement of mRNA jab litigation

Moderna's settlement of patent litigation with Arbutus and Genevant over technology used in its Spikevax COVID vaccine could reach up to $2.25bn.

News

Lungs computer graphic in palm of a doctor's hand

Roivant's new 'vant' emerges to advance Bayer lung drug

Roivant's latest biotech company launch – Pulmovant – has made its debut with a plan to develop a respiratory drug licensed from Bayer in a deal worth up to $294 million.

News

Rumour confirmed as Roche buys Telavant for $7.1bn

Roche has announced a $7.1 billion deal to acquire Roivant group company Telavant and its RVT-301 drug candidate for inflammatory bowel disease (IBD), confirming rumours t

News

Roche eyeing $7bn deal to buy Roivant drug; report

Roche is reported to be in the final stages of negotiating a deal with Roivant for an inflammatory bowel disease (IBD) candidate that could be worth up to $7 billion, acco

News

Vivek Ramaswamy confirms bid for US presidency

Biotech entrepreneur has launched his Vivek2024 campaign with an attack on the 'woke left'.

News

Pfizer and Roivant launch autoimmune specialist Priovant

The latest start-up to emerge from the Roivant stable is named Priovant Therapeutics, and has been formed to develop a JAK1/TYK2 inhibitor originated by Pfizer as a treatment for autoimmune

Moderna agrees $950m settlement of mRNA jab litigation

Roivant's new 'vant' emerges to advance Bayer lung drug

Rumour confirmed as Roche buys Telavant for $7.1bn

Roche eyeing $7bn deal to buy Roivant drug; report

Vivek Ramaswamy confirms bid for US presidency

Pfizer and Roivant launch autoimmune specialist Priovant

Hernexeos and what’s next, with Vicky Brown

Using AI-driven synthetic personas to take your insights fur...

Roivant

Editor's Picks